This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
A Study Evaluating Soticlestat in Participants With Dravet Syndrome or Lennox-Gastaut Syndrome Who Have Been Exposed to Fenfluramine | MicrobiomeTrials
← Back to trials NCT06422377
A Study Evaluating Soticlestat in Participants With Dravet Syndrome or Lennox-Gastaut Syndrome Who Have Been Exposed to Fenfluramine TERMINATED PHASE3 INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2024-04-25Est. Completion: 2024-08-14
Enrollment target: 1 participantsLocations Epilepsihospitalet Filadelfia, Dianalund, Region Sjælland, Denmark Other microbiome trials you might be interested in Dravet Syndrome (DS) Lennox-Gastaut Syndrome (LGS)
The goal of this clinical trial is to learn the best way to switch children with Lennox-Gastaut Syndrome (LGS) or Dravet…
Toronto, Canada Est. completion Jan 1, 2028
Dravet Syndrome (DS) Lennox Gastaut Syndrome (LGS)
The main aim of the study is to learn if soticlestat, when given as an add-on therapy, reduces the number of seizures in…
Phoenix, United States Completed Sep 24, 2025